|1.||Herold, Betsy C: 3 articles (01/2014 - 12/2005)|
|2.||Saaresranta, Tarja: 3 articles (01/2005 - 02/2004)|
|3.||Polo, Olli: 3 articles (01/2005 - 02/2004)|
|4.||Arnes, M: 2 articles (03/2014 - 12/2003)|
|5.||Straume, B: 2 articles (03/2014 - 12/2003)|
|6.||Yin, Yuzhi: 2 articles (03/2012 - 09/2005)|
|7.||Glazer, Robert I: 2 articles (03/2012 - 09/2005)|
|8.||Kopelovich, Levy: 2 articles (03/2012 - 09/2005)|
|9.||Chlebowski, Rowan T: 2 articles (02/2012 - 10/2009)|
|10.||Aragaki, Aaron K: 2 articles (02/2012 - 10/2009)|
|1.||Chronic Obstructive Pulmonary Disease (COPD)
01/01/2005 - "Medroxyprogesterone improves nocturnal breathing in postmenopausal women with chronic obstructive pulmonary disease."
10/01/2004 - "Significant improvement in arterial blood gas and ventilatory parameters was reported in COPD patients after acetazolamide and medroxyprogesterone treatment; however, with no improvement in survival or quality of life, the place of these drugs in therapy remains unknown."
10/01/2004 - "Trials are reviewed evaluating ventilatory parameters with acetazolamide and/or medroxyprogesterone in patients with COPD. "
11/01/2002 - "Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients."
08/01/1986 - "Previous studies have shown that some patients with chronic obstructive lung disease and hypercapnia will respond to medroxyprogesterone with improvement in arterial blood gases. "
01/01/1992 - "In the first approach medroxyprogesterone dosage increased up to 400 mg a day, achieved better results in curative as well as adjuvant treatment of advanced or early gynecologic cancers. "
08/01/1986 - "In this selected group of patients, oral medroxyprogesterone at a dose level of 400 mg/day appeared to provide a significant frequency of tumor response."
02/01/1981 - "Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone."
10/02/1976 - " In December 1974, a tumor was discovered and treated with medroxyprogesterone 250 mg/day. "
01/01/1991 - "In spite of the fact that progestagene receptors were not evidenced in two of our cases, one presented complete remission of the tumor after treatment with medroxyprogesterone. "
01/01/2013 - "Treatment with Medroxyprogesterone was 100% effective in terms of relapse, while Triptorelinum could not prevent recurrence of endometriosis."
07/01/2000 - "Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study."
12/01/1961 - " The 19-norsteroids and medroxyprogesterone are being used in the treatment of endometriosis. "
04/01/2007 - "We collected the samples of endometrium from patients with endometriosis before operation or after insertion of levenorgestrel releasing intrauterine system (LNG-IUS), administration of oral medroxyprogesterone (MPA), or injection of gonadotrophic hormone releasing hormone agonist (GnRHa). "
04/01/2007 - "To investigate the apoptosis-related mechanisms of levenorgestrel-releasing intrauterine system (LNG-IUS), oral medroxyprogesterone (MPA), and injective gonadotrophic hormone releasing hormone agonist (GnRHa) on eutopic endometrium of patients with endometriosis. "
12/01/1997 - "Uncomplicated amenorrhea in PCOS is managed with monthly or bimonthly administration of medroxyprogesterone. "
06/01/1994 - "Cyclic medroxyprogesterone increased spinal bone density in physically active women experiencing amenorrhea or ovulatory disturbances. "
04/15/1964 - "PROLONGED AMENORRHEA FOLLOWING MEDROXYPROGESTERONE."
10/01/1999 - "[Evaluation of safety in Chinese women with amenorrhea following injection of depot-medroxyprogesterone for contraception]."
05/01/1995 - "The role of orally administered medroxyprogesterone at a dose of 10 mg per day, 10 days per month, in improving BMD in teenage girls with hypothalamic amenorrhea or oligomenorrhea remains to be established. "
|5.||Respiratory Insufficiency (Respiratory Failure)
02/01/2004 - "This case documents successful control of chronic respiratory failure with medroxyprogesterone in a postmenopausal woman during 1-year follow-up."
02/01/2004 - "Medroxyprogesterone improves cardiac autonomic control in postmenopausal women with respiratory insufficiency."
08/01/2000 - "Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiency."
09/01/2002 - "This case documents the treatment of chronic type II respiratory failure secondary to central hypoventilation with medroxyprogesterone, a new treatment option."
07/01/1999 - "Two of these patients appeared to stabilise with no appreciable change clinically or in lung function on medroxyprogesterone and/or tamoxifen, but the remaining patients all deteriorated with two dying of respiratory insufficiency and one of infection following lung transplantation. "
|4.||Levonorgestrel (Plan B)
|2.||Intrauterine Devices (Intrauterine Device)
|3.||Hormone Replacement Therapy (Therapy, Hormone Replacement)
|5.||Contraception (Birth Control)